TCMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TCMD is not a good buy right now for an impatient entry. The setup is fundamentally improving (strong Q3 growth and clearly improving Wall Street view), but the near-term tape is soft (below pivot, weak momentum) and options flow is signaling short-term caution. I would hold off buying until price reclaims ~$29.63 (pivot) with follow-through, or it cleanly holds and bounces from the ~$28.37 support zone.
Trend/Momentum: TCMD is showing near-term weakness. RSI(6)=38.4 is leaning bearish (not oversold, but weak). MACD histogram at -0.328 is below zero (bearish momentum), though it is negatively contracting, which can hint that downside momentum is slowing rather than accelerating. Key levels: Pivot 29.63 is the line in the sand. Price (~28.87 post-market) is below pivot, implying a bearish-to-neutral posture until reclaimed. Support: S1 28.37 then S2 27.59. Resistance: R1 30.89 then R2 31.67. Moving averages: Converging MAs signal compression/indecision—often a prelude to a larger move, but direction is not confirmed. Price action context: Regular session was +0.98%, but pre-market indicated -2.83% weakness, consistent with the momentum indicators.
Intellectia Proprietary Trading Signals
Strong last reported quarter (2025/Q
with broad-based improvement: +17.3% YoY revenue, +59.2% YoY net income, EPS +71.4% YoY, and gross margin expansion to 75.1%.
Analyst tone has turned decisively more constructive: multiple upgrades/target raises and commentary around stabilization in lymphedema and AffloVest strength.
Potential pathway back to double-digit growth in FY26 cited by analysts.
Upcoming earnings catalyst: QDEC 2025 earnings on 2026-02-24 after hours (Street EPS est. ~0.44).
Near-term technicals are not confirming a clean uptrend: price below pivot (~29.63), MACD negative, RSI weak.
Options tape is cautious in the very short term: put volume dominates (put/call volume 4.
despite a more balanced OI structure.
No supportive near-term news flow in the past week to counteract technical softness.
Trading-trend data shows no strong accumulation signal from hedge funds/insiders recently (both described as Neutral).
Latest quarter: 2025/Q3. Growth and profitability improved materially: Revenue $85.76M (+17.32% YoY), Net Income $8.21M (+59.24% YoY), EPS $0.36 (+71.43% YoY), and Gross Margin 75.1% (+1.36% YoY). This is a strong quality-of-earnings profile (margin + EPS growth outpacing revenue), supporting the turnaround narrative.
Recent trend is strongly improving with higher price targets:
